Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

Androgens may increase arrhythmias in Brugada Syndrome, while Finasteride could reduce them.

The treatment combination is effective and generally safe for lung cancer.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Low-dose flutamide-metformin therapy effectively improved PCOS symptoms in adolescent girls.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Microemulsions could improve how drugs are delivered and absorbed in the body.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Spiritual well-being improves quality of life for Palestinian women with breast cancer.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

Spiritual well-being is crucial for improving quality of life in women with breast cancer.

The woman's rare combination of diseases suggests an unknown factor may predispose individuals to multiple endocrine diseases.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Cetuximab can cause unusual hair growth and hair loss.

Flutamide helps with prostate cancer and some skin conditions but can harm the liver.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

Anabolic androgenic steroids can increase cancer risk and disrupt hormones.

PCOS involves hormonal imbalance, cysts, and ovulation issues, affecting health and increasing disease risks.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Early sunburn treatment with certain inhibitors may reduce skin cancer risk.